HighTower Advisors’s GoodRx Holdings GDRX Stock Holding History
Bought
Maintained
Sold
Other funds holding GDRX
FPM
VCM
SLG
VPM
PTC
PGCM
HighTower Advisors's GDRX Position: Q1 2026 in Review
HighTower Advisors increased its GoodRx Holdings (GDRX) stake by 3.1% in Q1 2026, buying an estimated $4.02K and bringing the position to 57,844 shares worth $113K. The position accounts for ﹤0.01% of the portfolio, ranked #3615.
HighTower Advisors first reported a position in GDRX in Q4 2020 and has held it in 14 quarters since. The position peaked at $2.67M in Q1 2021. 174 funds tracked by Wall St. Rank hold GDRX as of Q1 2026.
- HighTower Advisors held 57,844 shares of GoodRx Holdings worth $113K as of Q1 2026.
- HighTower Advisors bought 1,715 GoodRx Holdings shares in Q1 2026, an estimated $4.02K.
- GoodRx Holdings made up ﹤0.01% of HighTower Advisors's portfolio in Q1 2026, its #3615 holding.
- HighTower Advisors first reported a position in GoodRx Holdings in Q4 2020 and has held it in 14 quarters since.
- HighTower Advisors's GoodRx Holdings position peaked at $2.67M in Q1 2021.
- 174 funds tracked by Wall St. Rank held GoodRx Holdings as of Q1 2026.
Based on HighTower Advisors's 13F filing for Q1 2026, filed 5 May 2026.